141 related articles for article (PubMed ID: 9893344)
1. Structure, expression and receptor-binding properties of placenta growth factor (PlGF).
Persico MG; Vincenti V; DiPalma T
Curr Top Microbiol Immunol; 1999; 237():31-40. PubMed ID: 9893344
[No Abstract] [Full Text] [Related]
2. The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution.
Iyer S; Leonidas DD; Swaminathan GJ; Maglione D; Battisti M; Tucci M; Persico MG; Acharya KR
J Biol Chem; 2001 Apr; 276(15):12153-61. PubMed ID: 11069911
[TBL] [Abstract][Full Text] [Related]
3. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta.
Hauser S; Weich HA
Growth Factors; 1993; 9(4):259-68. PubMed ID: 8148155
[TBL] [Abstract][Full Text] [Related]
4. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
5. Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling.
Beck H; Acker T; Püschel AW; Fujisawa H; Carmeliet P; Plate KH
J Neuropathol Exp Neurol; 2002 Apr; 61(4):339-50. PubMed ID: 11939589
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies.
Helske S; Vuorela P; Carpén O; Hornig C; Weich H; Halmesmäki E
Mol Hum Reprod; 2001 Feb; 7(2):205-10. PubMed ID: 11160848
[TBL] [Abstract][Full Text] [Related]
10. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells.
Barleon B; Hauser S; Schöllmann C; Weindel K; Marmé D; Yayon A; Weich HA
J Cell Biochem; 1994 Jan; 54(1):56-66. PubMed ID: 8126087
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor receptors in smooth muscle cells.
Ishida A; Murray J; Saito Y; Kanthou C; Benzakour O; Shibuya M; Wijelath ES
J Cell Physiol; 2001 Sep; 188(3):359-68. PubMed ID: 11473363
[TBL] [Abstract][Full Text] [Related]
13. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
Landgren E; Schiller P; Cao Y; Claesson-Welsh L
Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
[TBL] [Abstract][Full Text] [Related]
14. Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique.
Takahashi A; Sasaki H; Kim SJ; Kakizoe T; Miyao N; Sugimura T; Terada M; Tsukamoto T
Biochem Biophys Res Commun; 1999 Apr; 257(3):855-9. PubMed ID: 10208873
[TBL] [Abstract][Full Text] [Related]
15. The placenta growth factor gene of the mouse.
DiPalma T; Tucci M; Russo G; Maglione D; Lago CT; Romano A; Saccone S; Della Valle G; De Gregorio L; Dragani TA; Viglietto G; Persico MG
Mamm Genome; 1996 Jan; 7(1):6-12. PubMed ID: 8903720
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
[TBL] [Abstract][Full Text] [Related]
17. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.
Pepper MS; Baetens D; Mandriota SJ; Di Sanza C; Oikemus S; Lane TF; Soriano JV; Montesano R; Iruela-Arispe ML
Dev Dyn; 2000 Jul; 218(3):507-24. PubMed ID: 10878616
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor: possible role in fetal development and placental function.
Cheung CY
J Soc Gynecol Investig; 1997; 4(4):169-77. PubMed ID: 9292845
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.
He Y; Smith SK; Day KA; Clark DE; Licence DR; Charnock-Jones DS
Mol Endocrinol; 1999 Apr; 13(4):537-45. PubMed ID: 10194760
[TBL] [Abstract][Full Text] [Related]
20. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
